Accelerating Social Implementation of Digital Health Through a 'Corporate Accelerator' Model

BE Health (Headquarters: Taipei City), which specializes in supporting startups in the medical tech sector in Taiwan, has launched a strategic partnership with digital health company H2U (Headquarters: New Taipei City).

As the digital health market expands rapidly worldwide, the process of health tech startups transitioning from technological development to implementation in real-world society has garnered attention as a critical challenge. Many medical tech startups face difficulties in clinical introduction and market expansion even after product development is complete, highlighting problems such as a lack of actual service provision sites and difficulties in securing touchpoints with corporations and medical institutions.

Against this backdrop, a new industrial promotion model combining policy capital and industrial platforms has been forming in Taiwan in recent years. Efforts are underway to connect medical innovation from the R&D stage to practical application.

Among these, the 'Corporate Accelerator' model, which centers on medical accelerators collaborating with the demonstration and deployment environments possessed by corporations and platforms, is drawing attention as an important mechanism to accelerate the social implementation of medical innovation.

BE Health Ventures (Zhikang Fund), a venture capital firm under the BE Health umbrella, participated as the lead investor in H2U's latest funding round. Along with co-investments from the National Development Fund, they have achieved a total funding amount exceeding 100 million New Taiwan Dollars.

Furthermore, leveraging the expertise of 'BE Accelerator,' which has a track record of supporting over 200 domestic and international startups in Taiwan, they have jointly established the 'H2U × BE Corporate Accelerator.' This will build a new mechanism for innovation creation in the health tech sector through collaboration between corporations and startups.

BE Accelerator has consistently provided comprehensive support to med-tech startups, from product development and clinical validation to market introduction. Additionally, through the 'PoS (Proof of Strategic Partnership) Program,' they support the building of strategic collaborative relationships between large enterprises and startups. To date, they have accumulated a wealth of experience and knowledge in cross-border industrial collaboration, including running corporate accelerator partnerships with Japanese listed company Nitto Denko Corporation.

Meanwhile, H2U is developing a digital health management platform based on the integration of health data. Through innovative approaches, they aim to extend people's healthy lifespans, utilize technology to scale personalized health solutions, and promote the construction of a healthcare service ecosystem that connects individuals, corporations, and medical institutions.

For this initiative,